BioCentury | Jan 1, 2007
Strategy

Double-dipping on ProSkelia

...original merger - an anti-androgen program to treat acne and alopecia, as well as the trimegestone...
BioCentury | Jan 1, 2007
Company News

Galapagos, ProStrakan deal

...ProSkelia assets - an anti-androgen program to treat acne and alopecia, as well as the trimegestone...
BioCentury | Dec 27, 2006
Financial News

Galapagos raises EUR 31M, to acquire ProSkelia

...ProSkelia assets -- an anti-androgen program to treat acne and alopecia as well as the Trimegestone...
BioCentury | Jun 14, 2004
Company News

ProSkelia SA, Strakan deal

...after the deal. ProSkelia has three compounds in Phase II development, including PSK 3987 combined trimegestone-estradiol...
BioCentury | Jun 8, 2004
Top Story

Strakan to merge with ProSkelia

...the 50/50 merger. ProSkelia has three compounds in Phase II development including PSK 3987 combined trimegestone-estradiol...
BioCentury | Feb 2, 2004
Finance

Europe looking stuck

...Ind.). Phase IIa results are expected in the first quarter of 2005. Proskelia's Trim Patch trimegestone...
...patch, an HRT to treat osteoporosis, has completed a Phase II pharmacokinetics trial showing that trimegestone...
BioCentury | Oct 14, 2002
Emerging Company Profile

Proskelia: The future of HRT

...because we're about to start Phase III with our first compound," he said. Proskelia's Trimpatch trimegestone...
...the average age in the WHI was a bit high," he said. According to Ballero, trimegestone...
...terms of androgenic, glucocorticoid and mineralocorticoid activity," he said. "In clinical terms, that means that trimegestone...
BioCentury | Jul 15, 2002
Finance

Ebb & Flow

...Warburg Pincus putting E60 million ($58.4 million) into Aventis progeny ProSkelia . ProSkelia is developing trimegestone...
Items per page:
1 - 8 of 8